CNW/ – Servier Canada is pleased to announce the approval and commercial availability of VORANIGO™ (vorasidenib tablets), the first targeted therapy for the treatment of Grade 2 isocitrate ...
Oral cancer is a cancerous growth in the mouth, on the tongue, lips or gums. The most common type of oral cancer is squamous cell carcinoma. HPV-negative head and neck squamous cell carcinomas ...
However, given the recent failure of Sanofi's oral SERD amcenestrant in the ... with hormone receptor-positive, HER2-negative early breast cancer, which was reported at last year's ESMO meeting.